ID | 62644 |
フルテキストURL | |
著者 |
Hagiya, Hideharu
Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science
ORCID
Kaken ID
researchmap
Otsuka, Fumio
Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science
ORCID
Kaken ID
publons
researchmap
|
備考 | © 2021 Elsevier Inc. This manuscript version is made available under the CC-BY-NC-ND 4.0 License.http://creativecommons.org/licenses/by-nc-nd/4.0/.This is the accepted manuscript version. The formal published version is available at [https://doi.org/10.1016/j.clinthera.2021.07.007] .
|
発行日 | 2021-07-12
|
出版物タイトル |
Clinical Therapeutics
|
巻 | 43巻
|
号 | 9号
|
出版者 | Elsevier Inc.
|
開始ページ | 1622
|
終了ページ | 1623
|
ISSN | 01492918
|
NCID | AA00143411
|
資料タイプ |
学術雑誌論文
|
言語 |
英語
|
OAI-PMH Set |
岡山大学
|
著作権者 | © 2021 Elsevier Inc.
|
論文のバージョン | author
|
DOI | |
関連URL | isVersionOf https://doi.org/10.1016/j.clinthera.2021.07.007
|
ライセンス | http://creativecommons.org/licenses/by-nc-nd/4.0/
|
Citation | Hideharu Hagiya, Fumio Otsuka, Ivermectin for Coronavirus Disease 2019: Yet to Be Well Evaluated Before Clinical Use, Clinical Therapeutics, 2021, ISSN 0149-2918, https://doi.org/10.1016/j.clinthera.2021.07.007.
|
オープンアクセス(出版社) |
非OA
|
オープンアーカイブ(出版社) |
非OpenArchive
|